skip to main content

The Terry Fox Research Institute (TFRI), named for Canadian icon Terry Fox, is built on Terry's dream to end cancer through research.

News & Notices

  • Response to the Federal Government's budget announcement today regarding $150M for the Marathon of Hope Cancer Centres Network

    “We are thrilled with today’s announcement by the federal government to support the creation of the Marathon of Hope Cancer Centres. Under this new Terry Fox Research Network, Canadian cancer centres, together with their research teams from coast to coast, will share data, harmonize resources and apply new technologies such as genomics, advanced imaging and artificial intelligence, so that no matter where they live in Canada, cancer patients will have access to precision medicine – so the right treatment can be given to the right patient at the right time.” – Dr. Victor Ling, TFRI President and Scientific Director

    Read More View all notices

  • Blocking Type 1 Interferon reduces negative side-effects associated with potent immunotherapy

    A group of scientists from the TFRI-funded Canadian Oncolytic Virus Consortium (COVCo) has discovered a new way to reduce negative side-effects associated with a potent form of immunotherapy by blocking the expression of Type 1 Interferon (T1IFN), a key protein of the immune system.

    Read More View all notices

  • Restoring stem cells to a fetal-like state could provide a therapeutic alternative for acute leukemias

    A team of TFRI-funded scientists in Vancouver has discovered that restoring a signaling pathway that is prevalent in fetal stem cells but dormant in adult ones may provide an alterative treatment for acute T-cell leukemia (T-ALL).

    Read More View all notices

  • CEST MRI may be able to measure patient response to chemotherapy within 24 hours after first dosage

    TFRI researchers at Sunnybrook Hospital have found that CEST MRI technology can be used to detect cancer cell death in mice within 24 hours of receiving chemotherapy, much sooner than current methods.

    Read More View all notices


How new treatments and a strong support system gave new hope to this multiple myeloma patient

Trevor Richard had never heard of multiple myeloma before being diagnosed with the disease last year. Now, thanks to his family and his doctors, Richard is cancer free and has started doing what so many other cancer patients have done in the past: sharing his story – and his genetic data – to help others learn more about the disease, and feel better in the process. 

Read more  See more patient stories

Achieving Terry's Dream Through Research

Our Mission & Vision

Terry's vision unites us and inspires our research excellence, innovation and creativity. The Terry Fox Research Institute is a collaboratively oriented, pan-Canadian organization focused on improving cancer research outcomes for the benefit of cancer patients everywhere. We invest in and manage translational research projects across Canada and function as the research arm of The Terry Fox Foundation, managing and overseeing its discovery and training portfolios. We want to ensure that today’s best science becomes tomorrow’s affordable medicine.

Back to Top